Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 days ago

GENMAB A/S: ORBIS INVESTMENT MANAGEMENT LTD amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Orbis Investment Management Ltd amended its Schedule 13G filing on Genmab A/S with the SEC under accession number 0000940594-26-000071. The filing updates the investment manager's reported stake in the Danish biotech, though the headline did not disclose the revised share count or percentage. Schedule 13G amendments are typically filed when a passive holder's position moves past disclosure thresholds or otherwise changes materially. Genmab investors will watch for the full filing details to gauge whether Orbis increased or trimmed its holding.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Orbis Investment Management Ltd, Genmab A/S